Menu Search
Equities

Bioretec Oy

0TN:FRA

Bioretec Oy

Actions
  • Price (EUR)1.85
  • Today's Change0.03 / 1.65%
  • Shares traded10.00
  • 1 Year change-16.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Bioretec Oy had net income fall 54.02% from a loss of 2.42m to a larger loss of 3.72m despite a 32.78% increase in revenues from 2.94m to 3.91m. An increase in the cost of goods sold as a percentage of sales from 27.42% to 30.16% was a component in the falling net income despite rising revenues.
Gross margin69.97%
Net profit margin-86.61%
Operating margin-89.68%
Return on assets-35.54%
Return on equity-43.18%
Return on investment-40.92%
More ▼

Cash flow in EURView more

In 2023, Bioretec Oy increased its cash reserves by 465.13%, or 5.69m. Cash Flow from Financing totalled 9.29m or 237.72% of revenues. In addition the company used 3.44m for operations while cash used for investing totalled 161.35k.
Cash flow per share-0.1676
Price/Cash flow per share--
Book value per share0.318
Tangible book value per share0.2894
More ▼

Balance sheet in EURView more

Bioretec Oy appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 6.91m.
Current ratio4.87
Quick ratio4.04
Total debt/total equity0.0748
Total debt/total capital0.0696
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.